ArticleEuropean heart journal. Case reports2025
Left bundle branch area pacing in children: case series.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left bundle branch area pacing (LBBAP) is a new concept that provides physiological pacing with a narrow QRS duration. Recently published data suggest that LBBAP may prevent deleterious effects of right ventricular pacing, namely pacemaker-induced cardiomyopathy, especially in patients with expected high ventricular pacing burden, which may be of particular importance in children. Case summary: Herein, we report successful implantation of Medtronic SelectSecure (Model 3830, Medtronic Inc.) right ventricle electrode in the region of left bundle branch area in three consecutive children (two 16-year-old and one 8-year-old). Indication for pacemaker implantation was third-degree atrioventricular block in all cases. Implantations were performed under general anaesthesia, and there were no acute complications. During the median follow-up of 6 months, there were no adverse events and the electrical parameters of the device remained stable. Discussion: Compared with adult patients, implantation of pacemakers in children may still be challenging, not only because of smaller body size but also due to continuing growth and a higher rate of lead and device-related complications. We have demonstrated that implantation of LBBAP in children is feasible and could be worth considering, particularly in patients with expected high ventricular pacing burden. Further studies are needed to assess the efficacy and safety of LBBAP in children during long-term observation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.